Drug Shortage Report for FENTANYL CITRATE INJECTION, USP
Report ID | 170878 |
Drug Identification Number | 02501554 |
Brand name | FENTANYL CITRATE INJECTION, USP |
Common or Proper name | FENTANYL CITRATE INJECTION, USP |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | FENTANYL |
Strength(s) | 50MCG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR EPIDURAL |
Packaging size | 2mL |
ATC code | N01AH |
ATC description | ANESTHETICS, GENERAL |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-10-31 |
Actual start date | |
Estimated end date | 2023-01-23 |
Actual end date | 2023-01-13 |
Shortage status | Resolved |
Updated date | 2023-01-16 |
Company comments | Fresenius Kabi Canada regrets to advise that our available inventory of Fentanyl Citrate Injection, USP 50 mcg/mL 2 mL SD Vial is short dated. The current available inventory expires October 31, 2022. We will be facing a supply interruption as fresh inventory is expected to be available January 23, 2023. Please continue to order the short-dated product. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2023-01-16 | French | Compare |
v6 | 2023-01-16 | English | Compare |
v5 | 2022-11-11 | French | Compare |
v4 | 2022-11-11 | English | Compare |
v3 | 2022-11-01 | English | Compare |
v2 | 2022-10-02 | French | Compare |
v1 | 2022-10-02 | English | Compare |
Showing 1 to 7 of 7